Organo Corp is primarily present in several countries and regions around the world. Some key areas where the company has a significant presence include the United States, Canada, Japan, and various countries in Europe. Additionally, Organo Corp has expanded its operations to emerging markets in Asia, such as China and India, where it is actively expanding its market share. The company's global presence allows it to cater to diverse consumer demands and tap into various international markets for growth and development.

Organo Corp represents values of integrity, innovation, and customer focus. The company's corporate philosophy centers around delivering high-quality products and services that enhance the lives of individuals. Organo Corp prioritizes sustainable and ethical business practices, striving for long-term growth and contributing to the betterment of society. With a commitment to excellence and a customer-centric approach, Organo Corp aims to establish itself as a leader in its industry. By valuing honesty, creativity, and customer satisfaction, Organo Corp consistently strives to exceed expectations and build lasting relationships with its stakeholders.

The business model of Organo Corp revolves around the production and distribution of organic products. As a renowned company, Organo Corp focuses on providing high-quality organic goods to its customers. By utilizing sustainable farming practices and natural ingredients, the company aims to promote healthy living and environmental consciousness. Organo Corp's product range includes organic food, beverages, personal care items, and supplements, all crafted with utmost care to ensure the well-being of consumers. With its strong commitment to organic farming and sustainable practices, Organo Corp strives to be a leader in the organic industry and meet the growing demand for natural products worldwide.

Organo Corp is primarily active in the pharmaceutical and healthcare industries. With a focus on developing and manufacturing innovative medical solutions, Organo Corp has established itself as a key player in delivering high-quality healthcare products. Their extensive portfolio includes drugs, medical devices, and diagnostic equipment, enabling them to cater to various healthcare needs. Organo Corp's commitment to research and development further strengthens its position in these industries, allowing the company to make significant contributions to advancing healthcare worldwide.

The main competitors of Organo Corp in the market include companies such as ABC Company, XYZ Corporation, and DEF Inc. These companies operate in the same industry as Organo Corp and offer similar products and services. However, Organo Corp differentiates itself through its innovative technology, strong market presence, and superior customer service. As a leading player in the market, Organo Corp continuously strives to stay ahead of its competitors by focusing on research and development, strategic partnerships, and expanding its product portfolio.

Organo Corp is a renowned company with an impressive history and background. Established in [year], Organo Corp has consistently proved its expertise in [industry/sector]. Over the years, the company has garnered recognition for its innovative products and exceptional services. Organo Corp's commitment to excellence has allowed them to expand their reach globally, providing top-notch solutions to a diverse range of clients. With a strong emphasis on quality and customer satisfaction, Organo Corp has become a trusted name in the industry. Through continuous growth and strategic partnerships, the company has solidified its position as a leader in the market, setting new standards for success.

Organo Corp, a leading company in its industry, has achieved several significant milestones over the years. With a strong commitment to innovation and customer satisfaction, the company has successfully expanded its product offerings, maintained steady revenue growth, and strengthened its presence in the global market. Notably, Organo Corp has received numerous prestigious awards for its groundbreaking solutions and cutting-edge technologies. Through strategic partnerships and acquisitions, the company has enhanced its operational efficiency and diversified its portfolio. Organo Corp's dedication to research and development has allowed it to develop groundbreaking products that have revolutionized the industry. These milestones speak to Organo Corp's continuous success and position it as a frontrunner in the market.

Analysts currently set an average price target of 15 402,00 JPY for the Organo stock (median: 15 504,00 JPY), implying +4,0 % versus the latest price. The consensus is based on 8 analyst ratings.

Organo Analyytikkojen kursstavoitteet 2026

8 analysts currently rate the Organo stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Organo to generate revenue of 175,92 Mrd. JPY and earnings per share of 601,15 JPY.

Organo Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Organo share trades at 81,14 EUR (14 815,00 JPY).

Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. With a wide range of high-quality dietary supplements and wellness products, the company offers solutions for various health issues and supports people in enjoying their lives to the fullest. Answer: Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. They offer a wide range of high-quality dietary supplements and wellness products to help improve people's health and well-being.

odotettu liikevaihto Organo on 175,92 Mrd. JPY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Organo on 27,63 Mrd. JPY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Organo:n hinta-voitto-suhde (P/E) on tällä hetkellä 24,64. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Organo-osakkeen arvostusta.

Organo:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,87. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Organo-osakkeen arvostuskennuslukuna.

Organo:n Eulpool-laatuscore on 8/10.

Organo:n ISIN on JP3201600008. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Organo:n ticker on 6368.T. Tämä pörssinoteeraus käytetään Organo-osakkeiden kauppaan pörssissä.

Viimeisten 12 kuukauden aikana Organo maksoi osinkoa 184,00 JPY . Tämä vastaa osingontuottoa noin 1,24 %. Tulevien 12 kuukauden aikana Organo odotetaan maksavan osinkoa 346,80 JPY.

Organo:n nykyinen osinkotuotto on 1,24 %.

Organo maksaa osinkoa, joka jaetaan kuukausina , , , .

Organo maksoi osinkoa joka vuosi viimeisten 36 vuoden aikana.

Tulevien 12 kuukauden aikana odotetaan osinkoja, joiden määrä on 346,80 JPY. Tämä vastaa osingontuottoa 2,34 %.

Organo kuuluu sektoriin 'Teollisuus'.

Saadaksesi viimeisen osingon Organo:sta päivältä määrässä 95 JPY, sinulla piti olla osake portfoliossasi ennen irtoamispäivää .

Viimeinen osinko maksettiin .

Vuonna 2025 Organo jakoi 74 JPY osinkona.

Organo:n osingot jaetaan valuutassa JPY.